🚀 Accelerator💻 Tech🔥 Hot🟢 Ongoing
IndieBio — Early-Stage Biotech Accelerator
Up to $6–$525
Sign in to unlock your personalized workspace. Upgrade and view full role details.
About this Opportunity
IndieBio is the company’s flagship biotech accelerator with cohorts in San Francisco (Class 17, Batch 25H2) and New York (Class 9). Focused on biotech, synthetic biology, human health, and life sciences, IndieBio…
Compensation
Up to $525K total — $200K upfront Cash SAFE plus IndieBio SAFE (~$325K in lab space, equipment, on-site expertise) and Genesis Consortium SAFE at $6M cap, typically ~6-8% equity